| Date Filed | Type | Description |
| 06/12/2023 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Granted 16,985 options to buy
@ $26.25, valued at
$445.9k
|
|
| 01/04/2023 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 3,867 shares
@ $0
Granted 7,441 options to buy
@ $51.71, valued at
$384.8k
|
|
| 10/13/2022 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on COVETRUS, INC.|
Txns:
| Disposed/sold 13,275 shares
@ $0
Disposed/sold 14,638 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2022 |
3
| FONTEYNE PAUL R. (Director) has filed a Form 3 on GELESIS HOLDINGS, INC. |
| 01/10/2022 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Bought 3,947 shares
@ $19, valued at
$75k
Granted 8,400 options to buy
@ $19, valued at
$159.6k
|
|
| 01/06/2022 |
3
| FONTEYNE PAUL R. (Director) has filed a Form 3 on Amylyx Pharmaceuticals, Inc. |
| 01/04/2022 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 4,230 shares
@ $0
Granted 8,554 options to buy
@ $47.28, valued at
$404.4k
|
|
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on COVETRUS, INC.|
Txns:
| Granted 8,275 restricted stock units
@ $0 |
|
| 07/06/2021 |
3
| FONTEYNE PAUL R. (Director) has filed a Form 3 on COVETRUS, INC. |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 14,676 shares
@ $0
Disposed/sold 6,000 options to buy
@ $0
Disposed/sold 9,452 options to buy
@ $0
Disposed/sold 21,289 options to buy
@ $0 |
|
| 06/05/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $2.23, valued at
$32.1k
|
|
| 06/04/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on AMAG PHARMACEUTICALS, INC.|
Txns:
| Granted 10,269 shares
@ $0
Granted 21,289 options to buy
@ $8.52, valued at
$181.4k
|
|
| 05/12/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $31.8068, valued at
$159k
|
|
| 04/06/2020 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Granted 37,500 options to buy
@ $26.13, valued at
$979.9k
|
|
| 04/06/2020 |
3
| FONTEYNE PAUL R. (Director) has filed a Form 3 on Apellis Pharmaceuticals, Inc. |
| 10/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/09/2019 |
4
| FONTEYNE PAUL R. (Director) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Granted 14,414 options to buy
@ $7.99, valued at
$115.2k
|
|
| 01/25/2018 |
3
| FONTEYNE PAUL R. (Director) has filed a Form 3 on resTORbio, Inc. |